The importance of nutrivigilance in Middle East countries and the necessity for incorporation into pharmacovigilance health authorities’ regulations

BackgroundNutrivigilance has become increasingly vital as global supplement consumption rises. However, in many Middle Eastern countries, these products are marketed with limited oversight and minimal integration within existing pharmacovigilance systems.ObjectiveTo highlight the public health importance of nutrivigilance, review international models, and propose the incorporation of nutrivigilance practices into pharmacovigilance regulations within Middle Eastern health authorities.MethodsThis perspective synthesizes findings from global regulatory frameworks, including the U.S. FDA, European Food Safety Authority (EFSA), and national nutrivigilance programs and evaluates their applicability in Middle Eastern contexts.ResultsSignificant variability exists between countries regarding nutrivigilance implementation. Developed nations employ structured post-marketing surveillance systems, whereas Middle Eastern countries lack harmonized approaches. The absence of specialized nutrivigilance units and public awareness campaigns contributes to underreporting and potential adverse health outcomes. Integrating nutrivigilance into national pharmacovigilance programs could enhance consumer safety, regulatory decision-making, and data sharing.ConclusionEstablishing nutrivigilance within Middle Eastern pharmacovigilance regulations is an urgent public health priority. Creating dedicated departments, harmonizing standards, fostering regional collaboration, and enhancing reporting culture will strengthen safety monitoring and consumer protection.